• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

Congenica Raises Additional $17 Million to Reach Total of $30 Million in Series B Funding Round

April 30, 2019 By admin Leave a Comment

-Congenica, the global clinical decision support platform provider, today announced it has raised a further £13.25 ($17.1) million in additional equity investment, led by Parkwalk Advisors. The round attracted new strategic investors, including Digital China Health Technologies Corporation Limited (DCHealth), alongside follow-on funding from existing investors. The total amount raised across its B round financings is now £23.3 ($30.1) million.

Congenica was recently awarded a multi-year contract to be the exclusive provider of Diagnostic Decision Support Services for the world leading NHS Genomic Medicine Service, allowing clinicians to use its Sapientia™ platform and expert support services to interrogate the human genome to identify disease-causing variants. The company is now looking to accelerate growth, with commercial scale-up to support further penetration into international markets, to expand on the initial focus of the US and China.

In addition, the new capital will drive the development of an enhanced product platform that harnesses the power of statistics and machine learning technology to augment the ability of users to make diagnostic decisions. In parallel, new versions of the company’s SapientiaTM platform will incorporate extensive automation and broaden the clinical and commercial focus to support cancer treatment decisions, pharmacogenomics and health management.

Dr David Atkins, CEO of Congenica, said: “With the formalisation of our partnership with the NHS, we are now focused on accelerating the introduction of important new features to our platform. These funds will allow us to automate SapientiaTM, to support wider usage and reduce costs to healthcare providers, helping more clinicians provide accurate, rapid and cost-effective diagnoses to patients and their families.

“In addition, we can now begin to penetrate international markets. The deepening of our relationship with DCHealth gives us greater insight into the needs of the China market, with the recent development of an on-premise version of our platform the most notable example.”

Mr David Shi, CEO of DCHealth, commented: “As the provision of routine clinical genomics services continues to increase in China and other global markets, the challenge of analysis and interpretation of genomic data into meaningful, clinically-actionable results is coming into force. Our investment reflects Congenica’s proven abilities and track record and underlines our confidence that its platform and services will contribute to the new era of genomic medicine internationally.”

Dr Andy Richards, Chairman of Congenica, said: “Congenica is at the exciting scale-up stage of its commercial development, at the forefront of the fast-moving genomics market. Its recent successes demonstrate that, with the right investment and leadership, world-leading technology companies can be built from UK science. With this additional investment, Congenica is poised to become the leading clinical genomics service provider; and will benefit patients globally.”

About Congenica
Congenica is the provider of the diagnostic decision support platform, SapientiaTM, and associated clinical services, which enable clinicians to interrogate the human genome to identify disease-causing variants. 80% of rare diseases are thought to have a genetic component, and patients wait an average of 4.7 years, and typically see 7.4 different clinical specialists, before getting a diagnosis. SapientiaTM enables clinicians to progress through workflows more quickly, optimizing throughput of patients, number of patients diagnosed and reducing costs.

Headquartered in Cambridge, UK, and with a footprint in the US and China, Congenica is born out of pioneering research from the Wellcome Trust Sanger Institute and the NHS. Congenica was a partner for the pivotal Genomics England 100,000 Genomes Project and is now the exclusive provider of Diagnostic Decision Support Services for the NHS Genomic Medicine Service. To date the Company has raised a total of £26 ($33.5) million from investors including Parkwalk Advisors, Cambridge Innovation Capital (CIC), Amadeus Capital Partners, Future Planet Capital and now DCHealth.

For the full release please visit https://www.congenica.com/.

Filed Under: PR

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

Support for Vladimir Putin waning in Russia
Bread Starters as Online Business
Evolution of Luxury Watches
DeFiRetailing.com (DeFi Retailing): DeFi will change retail as we know it
Britain has built the world’s most advanced genome-sequencing infrastructure
The Army’s Robotic Combat Vehicle (RCV) Program
The U.S. is behind China on hypersonic weapon technology

Market Research Media

MultimodalRetail.com (Multimodal Retail): Should retailers split e-commerce operations from stores?
MetaversePolling.com (Metaverse Polling): What Do Consumers Think of the Metaverse?
Gaming-Disorder.com: Gaming disorder is now recognised by the World Health Organisation
AfricanInvesting.com (African Investing): Africa VC Funding Grew Exponentially in 2016-2021
Revenue from the metaverse is expected to reach $800 billion in 2024
Blockchaining.ai: What is Blockchain Technology and Why is it Popular
ESN.net, Event Sharing Network, Presents Upcoming Events

Secondary Sidebar

Technologies

Cloudflare R2 Storage directly challenges Amazon S3
Global power crunch: what you need to know
A world where energy is sustainable and abundant
A flurry of new product announcements from Apple and Canon
Arcitecta’s New High-Speed Data Mover Transfers Billions of Files Securely, Reliably, Globally at Ultra-Fast Rates

Tech Events

DVCon U.S. 2023 will be held February 27-March 2, 2023, at the Doubletree Hotel in San Jose, California
Graphene Week 2021, Europe’s leading graphene conference, September 20-24, 2021
The RISC-V Summit will be held at Moscone West in San Francisco from December 6-8, 2021
Snowflake Concludes Its Largest-Ever Global User Conference with New Innovations to Drive Application Development and Increased Collaboration in the Data Cloud
Bid Ops to Host Optimal ’22 Conference, March 23 – 24, 2022 in New York City

Footer

Recent Posts

  • How to achieving gender balance in management teams
  • When you feel like you’re spiraling
  • After Successful Tax Season, Embedded Tax Platform April Raises $30M Series A from Fintech Veterans
  • Vita Mojo Raises US$30 Million to Help Restaurant and Hospitality Chains in Europe Tackle the Digital Future
  • Nautical Commerce Raises $30M to Scale Multi-Vendor Marketplace Technology
  • Token Announces $13 Million Series B Funding Round and Appointment of New CEO to Disrupt the Authentication Market
  • Konnecto Raises $21M to establish a new category in marketing technology
  • Sharebite, the Leading Food Benefits Platform, Announces Closing of $39 Million Series B Round
  • Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
  • Biotech companies have received significant VC funding in the past three years

Dossier

Goodyear to Acquire Cooper, Creating Stronger U.S.-Based Leader in Global Tire Industry
Clean Shipping: Berge Bulk and Kongsberg Maritime join forces to advance marine decarbonisation
Box Opens Research and Development Engineering Site in Warsaw, Polan
Intalio Acquires Nyxeia
Microsoft acquires privileged access management vendor CloudKnox Security

Press Media Release

Apple Expands Today at Apple Creative Studios, Providing New Opportunities to Young Creatives
insightsoftware’s Embedded Analytics Solutions Named A Leader in 2022 Business Intelligence Market Study by Dresner Advisory Services
American Legion hails start of Operation Allies Refuge, Calls for Evacuations to Pick Up Pace
How to Write a Press Release Reporters Will Actually Read
“What to the Slave Is the 4th of July?”

App Coding

Code Intelligence raises $12M Series A
ScaleOut Software Announces Production Release of Redis®* Integration
Lumigo expands its serverless observability platform to support any modern cloud application
How to build a search engine
Configit Introduces Breakthrough System-Level Configuration Solution

API Coding

API-based startup that connects African businesses
LeadDev London! The event for engineering leaders
Five Steps to a Secure Cloud Architecture
Most commonly used HTTP Headers
One AI to Take on Global Language AI Challenge with NLP-as-a-service Platform for Developers

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT